These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 22920385)

  • 1. FDG PET/CT of a benign ovarian Brenner tumor.
    Toriihara A; Taniguchi Y; Negi M; Kubota K; Makino T; Shibuya H
    Clin Imaging; 2012; 36(5):650-3. PubMed ID: 22920385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Malignant ovarian Brenner tumor. A case report evaluated with (18)F-FDG PET/CT.
    Mena LM; Carmona E; Maza FR; Guiote MV; Moreno E; Vallejo JA
    Rev Esp Med Nucl Imagen Mol; 2015; 34(5):337-8. PubMed ID: 25890890
    [No Abstract]   [Full Text] [Related]  

  • 3. Assessment of combination of contrast-enhanced magnetic resonance imaging and positron emission tomography/computed tomography for evaluation of ovarian masses.
    Tsuboyama T; Tatsumi M; Onishi H; Nakamoto A; Kim T; Hori M; Sakane M; Hori Y; Morii E; Hatazawa J; Tomiyama N
    Invest Radiol; 2014 Aug; 49(8):524-31. PubMed ID: 24637584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spectrum of fluorodeoxyglucose-positron emission tomography/computed tomography and magnetic resonance imaging findings of ovarian tumors.
    Kitajima K; Ueno Y; Maeda T; Murakami K; Kaji Y; Kita M; Suzuki K; Sugimura K
    Jpn J Radiol; 2011 Nov; 29(9):605-8. PubMed ID: 21956364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [PET/CT scan with (18)F-FDG in re-staging of an atypical case of ovarian cancer].
    García Gómez FJ; Cuenca Cuenca JI; Acevedo Báñez I; Borrego Dorado I; Calvo García E; Vázquez Albertino RJ
    Rev Esp Med Nucl Imagen Mol; 2012; 31(4):223-4. PubMed ID: 23067691
    [No Abstract]   [Full Text] [Related]  

  • 6. The performance of contrast-enhanced FDG PET/CT for the differential diagnosis of unexpected ovarian mass lesions in patients with nongynecologic cancer.
    Lee JW; Lee JH; Cho A; Yun M; Lee JD; Kim YT; Kang WJ
    Clin Nucl Med; 2015 Feb; 40(2):97-102. PubMed ID: 25546187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 18F-FDG PET/CT and MR findings of ovarian carcinoid within a dermoid cyst.
    Horikawa M; Shinmoto H; Soga S; Miyai K; Kaji T
    Clin Nucl Med; 2014 Sep; 39(9):e392-4. PubMed ID: 24300346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A singular observation of a giant benign Brenner tumor of the ovary.
    Ruggiero S; Ripetti V; Bianchi A; La Vaccara V; Alloni R; Coppola R
    Arch Gynecol Obstet; 2011 Aug; 284(2):513-6. PubMed ID: 21594602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FDG-PET/CT as a molecular biomarker in ovarian cancer.
    Nowosinska E; Avril S; Murray I; Szyszko T; Avril N
    Cancer Biomark; 2010-2011; 8(4-5):167-75. PubMed ID: 22045351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unilateral ovarian metastasis from gastric mucinous adenocarcinoma visualized on FDG PET/CT.
    Tamam MO; Mulazimoglu M; Kamali G; Eker O; Ozpacaci T
    Eur Rev Med Pharmacol Sci; 2012 Oct; 16 Suppl 4():1-3. PubMed ID: 23090794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leydig cell tumour of the ovary localised with positron emission tomography/computed tomography.
    Prassopoulos V; Laspas F; Vlachou F; Efthimiadou R; Gogou L; Andreou J
    Gynecol Endocrinol; 2011 Oct; 27(10):837-9. PubMed ID: 21668318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FDG PET/CT in serous psammocarcinoma of the ovary.
    Dong A; Wang Y; Zuo C
    Clin Nucl Med; 2014 May; 39(5):453-5. PubMed ID: 23510884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of 18F-FDG PET/CT in diagnosing peritoneal carcinomatosis in the restaging of patient with ovarian cancer as compared to contrast enhanced CT and tumor marker Ca-125.
    Rubini G; Altini C; Notaristefano A; Merenda N; Rubini D; Ianora AA; Asabella AN
    Rev Esp Med Nucl Imagen Mol; 2014; 33(1):22-7. PubMed ID: 23948509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [CT features of ovarian Brenner tumor and a report of 9 cases].
    Wang XY; Dai JR; Zhu Z; Zhao YF; Zhou CW
    Zhonghua Zhong Liu Za Zhi; 2010 May; 32(5):359-62. PubMed ID: 20723434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive Oncologic Imaging in Infants and Preschool Children With Substantially Reduced Radiation Exposure Using Combined Simultaneous ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance Imaging: A Direct Comparison to ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography.
    Gatidis S; Schmidt H; Gücke B; Bezrukov I; Seitz G; Ebinger M; Reimold M; Pfannenberg CA; Nikolaou K; Schwenzer NF; Schäfer JF
    Invest Radiol; 2016 Jan; 51(1):7-14. PubMed ID: 26309185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of FDG-PET/CT in ovarian cancer patients with high tumor markers or suspicious lesion on contrast-enhanced CT in evaluation of recurrence and/or in determination of intraabdominal metastases.
    Sari O; Kaya B; Kara PO; Gedik GK; Celik C; Ozbek O; Serdengecti M
    Rev Esp Med Nucl Imagen Mol; 2012; 31(1):3-8. PubMed ID: 21549452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 18-fluorodeoxyglucose positron emission tomography enhances computed tomography diagnosis of malignant intraductal papillary mucinous neoplasms of the pancreas.
    Sperti C; Bissoli S; Pasquali C; Frison L; Liessi G; Chierichetti F; Pedrazzoli S
    Ann Surg; 2007 Dec; 246(6):932-7; discussion 937-9. PubMed ID: 18043094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physiologic FDG uptake in the ovary together with an abdominal wall leiomyoma mimicking metastasizing ovarian cancer on PET/CT imaging.
    Schwarz EI; Ramach C; Mende KA; Strobel K
    Clin Nucl Med; 2009 Apr; 34(4):249-50. PubMed ID: 19300062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Malignant Brenner tumor with transition from benign to malignant components: computed tomographic and magnetic resonance imaging findings with pathological correlation.
    Takeuchi M; Matsuzaki K; Sano N; Furumoto H; Nishitani H
    J Comput Assist Tomogr; 2008; 32(4):553-4. PubMed ID: 18664841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography in the characterization of pancreatic masses: experience from tropics.
    Santhosh S; Mittal BR; Bhasin D; Srinivasan R; Rana S; Das A; Nada R; Bhattacharya A; Gupta R; Kapoor R
    J Gastroenterol Hepatol; 2013 Feb; 28(2):255-61. PubMed ID: 23278193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.